The biotech industry’s biggest annual gathering, BIO2026, ran June 22-25 in San Diego. Nvidia showed up with something to say.
Nvidia’s VP of Healthcare, Kimberly Powell, joined Genentech CEO Ashley Magargee on a panel that put AI infrastructure at the center of the conversation about medicine’s future.
A partnership built on biological data and raw compute
The Nvidia-Genentech collaboration is not new. The two companies formalized a multi-year partnership on November 21, 2023, built around a specific idea: Genentech brings proprietary biological datasets, Nvidia brings the computing muscle.
Genentech, which operates as part of the Roche Group, sits on an enormous library of biological and clinical data accumulated over decades of drug development. Nvidia brings its BioNeMo platform and DGX Cloud infrastructure to process and model that data at scale.
